YOU ARE DOWNLOADING DOCUMENT

Please tick the box to continue:

Transcript
Page 1: Multiple Sclerosis

Multiple Sclerosis

Abdulelah NuqaliIntern

Page 2: Multiple Sclerosis
Page 3: Multiple Sclerosis
Page 4: Multiple Sclerosis

What is Multiple Sclerosis?

• Multiple Sclerosis (MS) is an acquired inflammatory demyelinating disease of the CNS (brain and spinal cord).

Page 5: Multiple Sclerosis

MS is a Demyelinating Disease

Myelin – provides insulation to nerve processes (axons)

Blood vessel

Blood vessel

Blood vessel

Inflammation

Inflammation

Inflammation

Myelin – provides insulation to nerve processes (axons)

Blood vessel

Blood vessel

Blood vessel

Blood vessel

Blood vessel

Blood vessel

Inflammation

Inflammation

Inflammation

Inflammation

Inflammation

Inflammation

Page 6: Multiple Sclerosis

How Common is MS and Who Gets It?

• 8,000 – 10,000 new cases are diagnosed annually• Affects nearly 500,000 individuals in the U.S.• Occurs most frequently between ages 25 - 35• Affects women 2 to 3 times as often as men• More frequent in populations native to areas further

away from the equator• Prevalence of MS in KSA is 4-8 cases per 100,000

Page 7: Multiple Sclerosis

What Causes MS?

• Unknown• Genetics• Environmental factors

Page 8: Multiple Sclerosis

Not Everyone with a Genetic Risk Will Develop MS – Why?

• Risk is modified by Environmental factors– Sunlight– Diet (e.g., vitamin D)– Other lifetime experiences (infections?)

Page 9: Multiple Sclerosis

Initial Presentation of MS

Incidence (%)

Optic nerve inflammation 14–29

Poor balance (ataxia) 2–18

Dizziness (vertigo) 2–9

Weakness 10–40

Double visions (diplopia) 8–18

Bladder, bowel dysfunction 0–14

Pain 21–40

Sensory loss 13–39

Page 10: Multiple Sclerosis

Other Common Symptoms of MS

•Fatigue•Spasticity•Sexual dysfunction•Cognitive impairment

–Generally occurs later in the disease

Page 11: Multiple Sclerosis

Multiple Sclerosis Clinical SubtypesMultiple Sclerosis Clinical Subtypes

Lublin FD et al. Neurology. 1996;46:907-911.

Relapsing-remitting

Primary-progressive

Dis

abili

ty

Time

Time

Dis

abili

tySecondary-progressive

Progressive-relapsing

Time

Time

Dis

abili

tyD

isab

ility

Page 12: Multiple Sclerosis

How Is MS Diagnosed?

• At least two episodes of symptoms – Occur at different points in time (DIT)– Result from involvement of different areas of

the central nervous system (DIS)

• Absence of other treatable causes for the symptoms

• Results of neurological testing

Page 13: Multiple Sclerosis

Examples of MS Onset• Case 1: 26 year old woman

– Decreased vision in the right eye in 9/05– Left leg numbness in 1/06– Right face numbness, right arm and leg weakness in 4/06 – Left leg weakness in 8/06

• Case 2: 45 year old man– Left arm weakness in 2/93– Numbness below the waist in 4/07

Page 14: Multiple Sclerosis

How Is MS Diagnosed?

Magnetic resonance imaging (MRI)CSF :• slight mononuclear pleocytosis or elevated in

protein• Increase IgG ( elevated IgG index OR the

presence of oligoclonal IgG bands )Visual evoked potentials

Page 15: Multiple Sclerosis

Magnetic Resonance Imaging in MS

Spinal cordOptic nerve

Brain

Spinal cordSpinal cordOptic nerveOptic nerve

BrainBrain

Page 16: Multiple Sclerosis

The 2010 McDonald Criteria for Diagnosis of MS

Page 17: Multiple Sclerosis

How is MS Treated and Managed?

• Drug therapy– Treat new attacks (exacerbations)– Prevent the occurrence of future attacks– Slow or prevent disease progression– Treat the chronic symptoms of the disease

• Physical therapy• Psychosocial support

Page 18: Multiple Sclerosis

Treatment of New MS Exacerbations

• Drug therapy– Corticosteroids– Intravenous immunoglobulin– Plasma exchange

• Physical therapy

Page 19: Multiple Sclerosis

Prevention of Future Attacks and Disease Progression

• Immune modulating drugs– Beta-Interferon– Glatiramer acetate– Humanized monoclonal antibodies

• Immunosuppressant drugs– Anti-cancer agents

• Combination therapies

Page 20: Multiple Sclerosis

Symptom Management – Examples

Symptom DrugSpasticity Baclofen

Trigeminal neuralgia & Dysethesias

Carbamazepine

Bladder Hyperactivity Anti- Cholinergics ( oxybutynin )

Urinary retention Cholinergics ( Bethanechol )

Fatigue SSRI ( fluoxetine )

Page 21: Multiple Sclerosis

Summary• MS is a common inflammatory disease of the CNS

that affects females more frequently than males.• The cause of MS appears to be a combination of

genetic and environmental factors.• The symptoms of MS can be quite variable.• MRI is a sensitive test for making the diagnosis of

MS.• Treatments are available for reducing the number of

MS attacks and for slowing MS disease progression.